Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Yale School of Medicine
New Haven, Estados UnidosPublicacións en colaboración con investigadores/as de Yale School of Medicine (11)
2024
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Seminars in Arthritis and Rheumatism, Vol. 65
-
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes
Nature Communications, Vol. 15, Núm. 1
-
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments
Seminars in Arthritis and Rheumatism, Vol. 65
2021
-
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 3, pp. 593-600
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Beneficial effects of bariatric surgery-induced by weight loss on the proteome of abdominal subcutaneous adipose tissue
Journal of Clinical Medicine, Vol. 9, Núm. 1
2019
2016
-
Empagliflozin and progression of kidney disease in type 2 diabetes
New England Journal of Medicine, Vol. 375, Núm. 4, pp. 323-334
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
2015
-
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
New England Journal of Medicine, Vol. 373, Núm. 22, pp. 2117-2128